// company-profile
Opus Genetics, Inc.
IRDExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings108Insiders19
// api This Opus Genetics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Opus Genetics, Inc. insiders bought $0 (7 transactions) and sold $7.6M (7 transactions).
- Most active insider: Foundation Fighting Blindness Retinal Degeneration Fund with 1 transaction totaling $7.4M.
- Largest single sale: $7.4M by Foundation Fighting Blindness Retinal Degeneration Fund on May 18, 2026.
Activity is mixed — buys and sales are roughly balanced.
Institutional Ownership
Top 13F-HR holders of Opus Genetics, Inc. as of 2026-03-31
Total reported AUM
$202.6M
QoQ change
+264.3%
Reporting period
2026-03-31
#1
Caligan Partners LP
CIK 1727492
$27.6M
6.1M shares
#2
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 1165408
$27.4M
6.0M shares
#3
BIOS Capital Management, LP
CIK 1813845
$16.8M
3.7M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | IRD | Sale | 1,700,000 | $4.35 | $7.39M |
| Apr 23, 2026 | Jayagopal Ashwath | IRD | Sale | 7,542 | $5.19 | $39K |
| Apr 23, 2026 | SCHACHLE JOSEPH K | IRD | Sale | 4,697 | $5.22 | $25K |
| Apr 23, 2026 | YERXA BENJAMIN R | IRD | Sale | 7,470 | $5.24 | $39K |
| Apr 23, 2026 | Zaremba Rabourn Amy | IRD | Sale | 1,641 | $5.20 | $9K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.